Consolidated Statement of Changes in Stockholders' Equity (Deficiency) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance (in shares) at Mar. 31, 2015	64,939,537
Balance at Mar. 31, 2015	$ 32,470	$ 32,298,094	$ (31,984,461)	$ 346,103
Net income			1,118,338	1,118,338
Balance at Mar. 31, 2016	33,504	33,195,759	(30,866,123)	2,363,140
Stock based compensation		598,699		598,699
Advanced Plasma Therapies stock purchase (in shares)	2,068,955
Advanced Plasma Therapies stock purchase	$ 1,034	298,966		$ 300,000
Balance (in shares) at Mar. 31, 2016	67,008,492			67,008,492
Stock Issued During Period, Shares, Issued for Services	580,000
Stock Issued During Period, Value, Issued for Services	$ 290	98,310		$ 98,600
Net income			1,205,760	1,205,760
Balance at Mar. 31, 2017	$ 33,794	$ 33,294,069	$ (29,660,363)	$ 3,667,500
Balance (in shares) at Mar. 31, 2017	67,588,492			67,588,492